Morgan Stanley (MS) — The Transparent Read
73/100Bullish$211.72 · uptrend
This is a healthy uptrend taking a breather, not a breakdown. The long-term and medium-term trends are clearly up, and the historical edge under this 'rising inflation, steady Fed' regime is hard to ignore — 84% higher with a double-digit median gain is a strong tailwind. The negative MACD and neutral RSI tell me the short-term tape is digesting recent gains, which is normal after a run. My lean is constructively bullish, with the caveat that the $205.83 support needs to hold to keep the thesis clean. Patience here is rewarded more than chasing.
MS key levels
Show Your Work — every point in MS's score
The score starts at 50, then each signal below adds or subtracts points. No black box.
| Signal | Type | Points |
|---|---|---|
| Above 200-day MA Price is above its 200-day average — long-term trend is up. | technical | +8 |
| Above 50-day MA Trading above the 50-day average — medium-term momentum is positive. | technical | +5 |
| Golden cross 50-day average is above the 200-day (golden cross). | technical | +4 |
| RSI neutral RSI is 50 — neither overbought nor oversold. | technical | -0.02 |
| MACD negative MACD is below its signal line — momentum is fading. | technical | -5 |
| Near support Holding near support around $205.83. | technical | +4 |
| Macro regime base rate In 38 past periods like today (Rising inflation + Steady Fed), this stock was higher 90d later 84% of the time (median +11.2%). Historically favorable. | macro | +6.84 |
Macro regime base rate
Today's regime: Rising inflation + Steady Fed
In 38 past periods that looked like today, MS was higher 90 days later 84% of the time (median move 11.2%). Confidence: high.
The read
Morgan Stanley Holds the High Ground — Trend Up, Momentum Catching Its Breath
Bull case. MS is firmly in an uptrend, trading at $211.72 above both its 50-day ($202.35) and 200-day ($176.30) moving averages, with a golden cross confirming the structure. The composite score of 72.8/100 is solidly bullish. Most compelling: the macro backdrop. In 38 prior periods of rising inflation with a steady Fed, MS finished higher 90 days later 84% of the time, with a median gain of +11.2% — high confidence. Price is also holding near support at $205.83, a logical spot for buyers to defend.
Bear case. Momentum is fading. The MACD histogram is negative (-1.54) and sitting below its signal line, a sign the recent advance is losing steam. RSI at exactly 50 is dead neutral — no conviction in either direction right now. With resistance overhead at $230.47, the stock has work to do before the next leg up, and a slip below the $205.83 support would crack the near-term floor.
What would change my mind. A decisive close below the $205.83 support would invalidate the near-term bullish read and put the 50-day MA at $202.35 in play next. Combine that with a deepening negative MACD and the 'breather' narrative becomes a deterioration narrative.
MS — frequently asked
Is MS a buy according to Tallyread?
Tallyread does not give buy or sell recommendations. It shows a transparent 73/100 read for Morgan Stanley (MS), conditioned on today's macro regime, with every scoring input itemized so you can judge for yourself. This is not financial advice.
How is MS's Tallyread score calculated?
The 73/100 score starts at 50, then adds and subtracts named technical and macro signals — each shown with its point value and a one-line reason in the "Show Your Work" table on this page. Nothing is hidden in a black box.
How does today's Fed-and-inflation regime affect MS?
In 38 past periods whose macro regime matched today's (Rising inflation + Steady Fed), MS was higher 90 days later 84% of the time, with a median move of 11.2%. Confidence: high.
Want a fresh read on MS with the live chart and macro tape?
Run a live MS read →Last analyzed 2026-06-30 · Data source: tiingo. See the public scorecard and methodology.
This is a historical and technical read for informational and educational purposes only — not financial advice, and not a recommendation to buy or sell MS. Markets are uncertain; do your own research.